[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100484443":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":28,"responsibleParty":58,"collaborators":60,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":64,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":10,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"University of Calgary","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Concussion",null,"Patients presenting to the ED who are diagnosed with concussion according to the ICD-10 criteria and absent of comorbidities.",{"label":13,"type":10,"description":14,"interventionNames":10},"MSK","Patients presenting to the ED who are diagnosed with a muscle or skeletal injury (MSK; soft tissue damage or inflammation, fractured bone, etc.) and absent of comorbidities.",[16],{"name":17,"affiliation":5,"role":18},"Chantel T Debert, MD, MSc","PRINCIPAL_INVESTIGATOR",[20,24],{"name":17,"role":21,"phone":22,"phoneExt":10,"email":23},"CONTACT","4039444500","cdebert@ucalgary.ca",{"name":25,"role":21,"phone":26,"phoneExt":10,"email":27},"Linden C Penner, MSc","7802631373","linden.penner@ucalgary.ca",[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Foothills Medical Centre","RECRUITING","Calgary","Alberta","T2N 2T9","Canada","CA",{"type":38,"coordinates":39},"Point",[40,41],-114.08529,51.05011,{"lat":41,"lon":40},[44,48,52,53,56],{"name":45,"role":21,"phone":46,"phoneExt":10,"email":47},"Bianca M Perry, MSc","4039448643","bianca.perry@ucalgary.ca",{"name":49,"role":21,"phone":50,"phoneExt":10,"email":51},"Christina Campbell, MSc","(403)944-8643","Christina.Campbell@albertahealthservices.ca",{"name":17,"role":18,"phone":10,"phoneExt":10,"email":10},{"name":54,"role":55,"phone":10,"phoneExt":10,"email":10},"Amir Sanati-Nezhad, MD","SUB_INVESTIGATOR",{"name":57,"role":55,"phone":10,"phoneExt":10,"email":10},"Kathryn Crowder, MD",{"type":59,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[61],{"name":30,"class":6},"100484443","rapid-accurate-cost-effective-assessment-of-blood-biomarkers-for-diagnosis-of-concussion-100484443",false,"NCT05588115","Rapid, Accurate, Cost-effective Assessment of Blood Biomarkers for Diagnosis of Concussion","RACE Study: Rapid, Accurate and Cost-effective Analysis of Glial Fibrillary Acid Protein Using a Hand-held Biosensor for Patient With Concussion in Acute Care and at Home Monitoring","RACE","Inclusion Criteria (concussion group):\n\n1. diagnosed with an uncomplicated concussion according to the ICD-10 criteria with no intracranial abnormalities\n2. between the ages of 18-65 years old.\n\nInclusion Criteria (MSK group):\n\n1. diagnosed with any form of musculoskeletal injury in absence of comorbidities\n2. between the ages of 18-65 years old\n\nExclusion Criteria:\n\n1. complicated mild TBI (positive neuroimaging findings)\n2. current or history of moderate or severe traumatic brain injury\n3. history of neurological issue(s) (stroke, seizures, dementia, Alzheimer's, etc.) or metabolic disease(s) (diabetes, liver disease, kidney disease, cardiovascular disease, etc.)\n4. greater than 7 days from injury at initial visit","ALL","18 Years","65 Years",{"count":74,"type":75},225,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to test if a biosensor can accurately measure a blood biomarker in adult patients presenting to the emergency department with concussion. The main questions it aims to answer are:\n\n* Does the biosensor measure the blood biomarker of interest with the same accuracy as the current gold-standard assay technique?\n* Do relationships exist between blood biomarker measurements from the biosensor and any psychological or physical symptoms of concussion?\n\nParticipants will be asked to provide blood samples at initial visit and 2-, 6-, and 12-weeks after injury while completing questionnaires at each visit, along with a brief (2 min) daily symptom inventory.\n\nResearchers will compare the concussion group to a muscle\u002Fskeletal injury group to see if measurements from the biosensor are exclusive to concussion.",[79],"Concussion, Mild",[81,82,83,84],"blood biomarkers","GFAP","biosensor","concussion","2026-02-02",{"date":87,"type":88},"2026-02-05","ACTUAL",{"date":90,"type":88},"2022-12-01",{"date":92,"type":75},"2027-12",{"name":5,"class":6},1]